211 related articles for article (PubMed ID: 36153432)
1. The Promising Epigenetic Regulators for Refractory Epilepsy: An Adventurous Road Ahead.
Suvekbala V; Ramachandran H; Veluchamy A; Mascarenhas MAB; Ramprasath T; Nair MKC; Garikipati VNS; Gundamaraju R; Subbiah R
Neuromolecular Med; 2023 Jun; 25(2):145-162. PubMed ID: 36153432
[TBL] [Abstract][Full Text] [Related]
2. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
3. Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program.
Pernici CD; Mensah JA; Dahle EJ; Johnson KJ; Handy L; Buxton L; Smith MD; West PJ; Metcalf CS; Wilcox KS
Epilepsia; 2021 Jul; 62(7):1665-1676. PubMed ID: 34002394
[TBL] [Abstract][Full Text] [Related]
4. Mutation spectrum of the SCN1A gene in a Hungarian population with epilepsy.
Till Á; Zima J; Fekete A; Bene J; Czakó M; Szabó A; Melegh B; Hadzsiev K
Seizure; 2020 Jan; 74():8-13. PubMed ID: 31765958
[TBL] [Abstract][Full Text] [Related]
5. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW
Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421
[TBL] [Abstract][Full Text] [Related]
6. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
[TBL] [Abstract][Full Text] [Related]
7. Determination of SCN1A genetic variants in Mexican patients with refractory epilepsy and Dravet syndrome.
Jiménez-Arredondo RE; Brambila-Tapia AJL; Mercado-Silva FM; Magaña-Torres MT; Figuera LE
Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28525652
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Haploinsufficient Gene Expression in the Brain by Targeting a Long Non-coding RNA Improves Seizure Phenotype in a Model of Dravet Syndrome.
Hsiao J; Yuan TY; Tsai MS; Lu CY; Lin YC; Lee ML; Lin SW; Chang FC; Liu Pimentel H; Olive C; Coito C; Shen G; Young M; Thorne T; Lawrence M; Magistri M; Faghihi MA; Khorkova O; Wahlestedt C
EBioMedicine; 2016 Jul; 9():257-277. PubMed ID: 27333023
[TBL] [Abstract][Full Text] [Related]
9. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
Niibori Y; Lee SJ; Minassian BA; Hampson DR
Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
[TBL] [Abstract][Full Text] [Related]
10. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
Miller AR; Hawkins NA; McCollom CE; Kearney JA
Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
[TBL] [Abstract][Full Text] [Related]
11. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.
Schutte RJ; Schutte SS; Algara J; Barragan EV; Gilligan J; Staber C; Savva YA; Smith MA; Reenan R; O'Dowd DK
J Neurophysiol; 2014 Aug; 112(4):903-12. PubMed ID: 24805083
[TBL] [Abstract][Full Text] [Related]
12. Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11.
Kearney JA; Copeland-Hardin LD; Duarte S; Zachwieja NA; Eckart-Frank IK; Hawkins NA
Mamm Genome; 2022 Dec; 33(4):565-574. PubMed ID: 35606653
[TBL] [Abstract][Full Text] [Related]
13. Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
Li W; Schneider AL; Scheffer IE
Epilepsia; 2021 Sep; 62(9):2205-2217. PubMed ID: 34338318
[TBL] [Abstract][Full Text] [Related]
14. A 5-HT
Hatini PG; Commons KG
Eur J Neurosci; 2020 Nov; 52(10):4370-4374. PubMed ID: 32394465
[TBL] [Abstract][Full Text] [Related]
15. Investigation of MicroRNA-134 as a Target against Seizures and SUDEP in a Mouse Model of Dravet Syndrome.
Gerbatin RR; Augusto J; Morris G; Campbell A; Worm J; Langa E; Reschke CR; Henshall DC
eNeuro; 2022; 9(5):. PubMed ID: 36240080
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-335-5p suppresses voltage-gated sodium channel expression and may be a target for seizure control.
Heiland M; Connolly NMC; Mamad O; Nguyen NT; Kesavan JC; Langa E; Fanning K; Sanfeliu A; Yan Y; Su J; Venø MT; Costard LS; Neubert V; Engel T; Hill TDM; Freiman TM; Mahesh A; Tiwari VK; Rosenow F; Bauer S; Kjems J; Morris G; Henshall DC
Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2216658120. PubMed ID: 37463203
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Prediction Model for Early Diagnosis of
Brunklaus A; Pérez-Palma E; Ghanty I; Xinge J; Brilstra E; Ceulemans B; Chemaly N; de Lange I; Depienne C; Guerrini R; Mei D; Møller RS; Nabbout R; Regan BM; Schneider AL; Scheffer IE; Schoonjans AS; Symonds JD; Weckhuysen S; Kattan MW; Zuberi SM; Lal D
Neurology; 2022 Mar; 98(11):e1163-e1174. PubMed ID: 35074891
[TBL] [Abstract][Full Text] [Related]
18. Early clinical features and diagnosis of Dravet syndrome in 138 Chinese patients with SCN1A mutations.
Xu X; Zhang Y; Sun H; Liu X; Yang X; Xiong H; Jiang Y; Bao X; Wang S; Yang Z; Wu Y; Qin J; Lin Q; Wu X
Brain Dev; 2014 Sep; 36(8):676-81. PubMed ID: 24168886
[TBL] [Abstract][Full Text] [Related]
19. Seizure precipitants in Dravet syndrome: What events and activities are specifically provocative compared with other epilepsies?
Verbeek NE; Wassenaar M; van Campen JS; Sonsma A; Gunning B; Knoers N; Lindhout D; Jansen FE; Leijten F; Brilstra EH; Kasteleijn-Nolst Trenité D
Epilepsy Behav; 2015 Jun; 47():39-44. PubMed ID: 26021464
[TBL] [Abstract][Full Text] [Related]
20. Vaccination and occurrence of seizures in SCN1A mutation-positive patients: a multicenter Italian study.
Zamponi N; Passamonti C; Petrelli C; Veggiotti P; Baldassari C; Verrotti A; Capovilla G; Viri M; Coppola G; Vignoli A
Pediatr Neurol; 2014 Mar; 50(3):228-32. PubMed ID: 24405698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
